17 results for "Gu, Li-Hui"
Showing 1–17 · 0.87 seconds · RSS
-
Journal Article Full text
Neoadjuvant immunotherapy for hepatocellular carcinoma: progress and perspectives
-
Journal Article Full text
NRG1/PDGFC loop between fibroblasts and cancer cells drives paclitaxel resistance via ferroptosis suppression in breast cancer
Breast cancer (BC) is one of the leading diseases that severely threaten women’s lives and health worldwide, with chemoresistance remaining a major challenge in its treatment. The tumor microenvironment, particularly cancer-associated fibroblasts (CAFs), plays a critical role in the chemoresistance…
-
Journal Article Full text
Molecular mechanisms and potential targeting strategies of ubiquitin-proteasome system-mediated PD-1/PD-L1 ubiquitination in tumor immune suppression (Review)
Cancer cells play a pivotal role in immune evasion by activating the programmed cell death protein 1 (PD-1)/PD-ligand (L)1 signaling pathway or immune cells within the tumor microenvironment. The ubiquitin-proteasome system (UPS), the primary pathway for intracellular protein degradation, has been…
-
Journal Article Full text
MAGI2-AS3/miR-450b-5p/COLEC10 interaction network: A potential therapeutic and prognostic marker in hepatocellular carcinoma
BACKGROUND AND AIMS: Hepatocellular carcinoma (HCC) is a prevalent malignancy with poor prognosis. This study uses integrated bioinformatic analyses to explore potential competing endogenous RNA (ceRNA) network chains in HCC. METHODS: HCC expression profile data were obtained from the Gene…
-
Journal Article Full text
Mesoporous Nanoparticles for Diagnosis and Treatment of Liver Cancer in the Era of Precise Medicine
Primary liver cancer is the seventh-most-common cancer worldwide and the fourth-leading cause of cancer mortality. In the current era of precision medicine, the diagnosis and management of liver cancer are full of challenges and prospects. Mesoporous nanoparticles are often designed as specific…
-
Journal Article Full text
Molecular mechanisms of programmed cell death and potential targeted pharmacotherapy in ischemic stroke (Review)
Stroke poses a threat to the elderly, being the second leading cause of death and the third leading cause of disability worldwide. Ischemic stroke (IS), resulting from arterial occlusion, accounts for ~85% of all strokes. The pathophysiological processes involved in IS are intricate and complex…
-
Journal Article Full text
miR-141-3p promotes paclitaxel resistance by attenuating ferroptosis via the Keap1-Nrf2 signaling pathway in breast cancer
Purpose: Breast cancer poses a huge threat to the lives and health of women worldwide. However, drug resistance makes the treatment of breast cancer challenging. This study aims to investigate the effect of miR-141-3p on paclitaxel resistance and its underlying mechanisms in breast cancer. Methods…
-
Journal Article Full text
Conversion therapy for advanced hepatocellular carcinoma in the era of precision medicine: Current status, challenges and opportunities
Hepatocellular carcinoma (HCC), the most prevalent malignancy of the digestive tract, is characterized by a high mortality rate and poor prognosis, primarily due to its initial diagnosis at an advanced stage that precludes any surgical intervention. Recent advancements in systemic therapies have…
-
Journal Article Full text
Hydrogel Crosslinked with Nanoparticles for Prevention of Surgical Hemorrhage and Recurrence of Hepatocellular Carcinoma (Adv. Sci. 9/2024)
Immunotherapy In article number 2305508, Dong‐Sheng Huang, Tian Yang, and co‐workers report a functional and welldesigned hydrogel with controllable biocompatibility, abbreviated as A+T‐loaded MgCa(CO(3))(2)@fibrin (A+T@MgCa(CO(3))(2)@fibrin). In this study, an injectable hydrogel drug delivery…
-
Journal Article Full text
Hydrogel Crosslinked with Nanoparticles for Prevention of Surgical Hemorrhage and Recurrence of Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is acknowledged as an immunosuppressive neoplasm, whereby the inactive microenvironment facilitates immune tolerance and evasion of HCC. Post‐surgical resected liver cancer exhibits a proclivity for relapse, rendering prevention of recurrence challenging as it may…
-
Journal Article Full text
Emerging role of molecular diagnosis and personalized therapy for hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is a prevalent malignancy worldwide, ranking as the sixth most common malignancy and the third leading cause of cancer-related mortality. Late diagnosis, limited management options, and its complex etiology contribute to the poor prognosis and high mortality rates…
-
Journal Article Full text
ASAP Score versus GALAD Score for detection of hepatitis C-related hepatocellular carcinoma: A multicenter case-control analysis
BACKGROUND: The GALAD and ASAP scores are two well-recognized algorithms to estimate the risk of hepatocellular carcinoma (HCC) based on gender, age, alpha-fetoprotein (AFP), protein induced by vitamin K absence or Antagonist-II (PIVKA-II) and AFP-L3 (included in the GALAD score but not in the ASAP…
-
Journal Article Full text
Grading severity of microscopic vascular invasion was independently associated with recurrence and survival following hepatectomy for solitary hepatocellular carcinoma
BACKGROUND: Hepatectomy is the preferred treatment for solitary hepatocellular carcinoma (HCC) without macrovascular invasion and distant metastasis, but long-term survival remains unsatisfactory in certain patients. We sought to identify whether the grading severity of microscopic vascular…
-
Journal Article Full text
Association of preoperative frailty with short- and long-term outcomes after hepatic resection for elderly patients with hepatocellular carcinoma: multicentre analysis
BACKGROUND: The growing demand for surgical resection in elderly patients with hepatocellular carcinoma highlights the need to understand the impact of preoperative frailty on surgical outcomes. The aim of this multicentre cohort study was to investigate the association between frailty and short-…
-
Journal Article Full text
Prognostic Value of the ASAP Score for Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma: A Multicenter Analysis of 1,239 Patients
BACKGROUND AND AIMS: The ASAP score, which incorporates age, sex, alpha-fetoprotein (AFP), and protein induced by vitamin K absence-II, has demonstrated promise for early detection of hepatocellular carcinoma (HCC). However, its prognostic value after HCC treatment remains unknown. The current…
-
Journal Article Full text
α-Fetoprotein model versus Milan criteria in predicting outcomes after hepatic resection for hepatocellular carcinoma: multicentre study
BACKGROUND: The Milan criteria and the French α-fetoprotein (AFP) model have both been validated for predicting outcomes after liver transplantation for hepatocellular carcinoma, with the Milan criteria also used for predicting outcomes after hepatic resection. The aim of this study was to evaluate…
-
Journal Article Full text
Development and validation of an individualized online calculator for early mortality risk after hepatectomy among patients with HCC
BACKGROUND AND AIMS: Hepatocellular carcinoma (HCC) is a leading cause of cancer death globally. Despite improved surgical techniques, early post-hepatectomy mortality remains a critical concern. Current staging systems and liver function classifications fail to estimate early mortality risk to…